Skip to main
HQY

HealthEquity (HQY) Stock Forecast & Price Target

HealthEquity (HQY) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 64%
Hold 0%
Sell 0%
Strong Sell 9%

Bulls say

HealthEquity is well-positioned for long term success as it continues to expand its market share and revenue growth through strategic investments in technology and sales and marketing. The company's strong financials, including revenue of over $1 billion, an above-average combination of revenue growth and EBITDA margins, and a recurring revenue platform business model, support a multipleratingis justified. However, potential risks to the company's success include a weakening labor market, increasing competition, and changes in the regulatory environment.

Bears say

HealthEquity is facing strong competition from other healthcare-focused players such as Optum Bank and Bank of America, and its primary source of revenue relies heavily on HSAs. However, with the regulatory landscape improving for HSA eligibility expansion and inorganic growth opportunities in the fragmented market, there is potential for long-term growth. Additionally, the company has a strong leadership team, a solid balance sheet, and has shown a commitment to sustainability through its corporate sustainability committee and various employee resource groups.

HealthEquity (HQY) has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 64% recommend Buy, 0% suggest Holding, 0% advise Selling, and 9% predict a Strong Sell.

This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HealthEquity (HQY) Forecast

Analysts have given HealthEquity (HQY) a Buy based on their latest research and market trends.

According to 11 analysts, HealthEquity (HQY) has a Buy consensus rating as of Aug 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $114.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $114.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HealthEquity (HQY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.